General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 571: Tissue biopsy for histopathological examination should be sent in which of the following?

A. Normal saline
B. Formalin (Correct Answer)
C. Rectified spirit
D. Saturated solution of saline

Explanation: **Explanation:** The primary goal of histopathological examination is to preserve the tissue in a state as close to its living condition as possible. This is achieved through **fixation**, which prevents autolysis (self-digestion by enzymes) and putrefaction (bacterial decomposition). [1] **Why Formalin is the Correct Answer:** The standard fixative used worldwide is **10% Neutral Buffered Formalin (NBF)**. It is an aldehyde fixative that works by creating **cross-links between proteins** (specifically lysine residues), forming a "gel" that stabilizes the cellular structure and hardens the tissue. It is preferred because it preserves morphology excellently, is inexpensive, and allows for a wide range of subsequent stains, including H&E and Immunohistochemistry (IHC). [1] **Analysis of Incorrect Options:** * **Normal Saline (A):** Saline is not a fixative. While it can keep tissue moist for a very short duration (e.g., during transport for an immediate frozen section), it does not prevent autolysis. [1] Prolonged immersion leads to tissue degradation. * **Rectified Spirit/Alcohol (C):** While alcohol is a fixative, it causes significant **tissue shrinkage** and hardening by dehydrating the cells. It is generally reserved for cytology smears (e.g., Pap smears) rather than bulk tissue biopsies. [1] * **Saturated Saline (D):** This is not used in standard pathology. High salt concentrations cause osmotic distortion of cells, making microscopic diagnosis impossible. **High-Yield Clinical Pearls for NEET-PG:** * **Ideal Ratio:** The volume of fixative should be **10 to 20 times** the volume of the tissue specimen. * **Fixation Rate:** Formalin penetrates tissue at a rate of approximately **1 mm per hour**. * **Glutaraldehyde:** The fixative of choice for **Electron Microscopy**. * **Carnoy’s Fluid:** A rapid fixative used for nuclear preservation and identifying glycogen. * **Bouin’s Solution:** Often used for testicular and GI biopsies to preserve delicate morphology. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 25-26.

Question 572: Which of the following is NOT a primary cause of non-inflammatory edema?

A. Increased intravascular hydrostatic pressure
B. Increased vascular permeability (Correct Answer)
C. Decreased plasma colloid oncotic pressure
D. Lymphatic obstruction

Explanation: **Explanation:** The fundamental distinction in edema is between **transudate** (non-inflammatory) and **exudate** (inflammatory). **Why Option B is the correct answer:** **Increased vascular permeability** is the hallmark of **inflammatory edema (exudate)** [1]. During inflammation, chemical mediators (like histamine and leukotrienes) cause endothelial cell contraction or injury, creating gaps in the vessel wall [1]. This allows protein-rich fluid and cells to leak into the interstitial space. Because the primary mechanism involves an inflammatory response, it is not classified as non-inflammatory edema. **Why the other options are incorrect:** These three mechanisms lead to **non-inflammatory edema (transudate)**, where the fluid is protein-poor and the vascular wall remains intact: * **A. Increased Hydrostatic Pressure:** Commonly seen in Congestive Heart Failure (CHF) or Deep Vein Thrombosis (DVT), where impaired venous return pushes fluid out of capillaries [2]. * **C. Decreased Plasma Colloid Oncotic Pressure:** Occurs when albumin is lost (Nephrotic syndrome) or not produced (Liver cirrhosis), reducing the "pull" that keeps fluid inside vessels [2]. * **D. Lymphatic Obstruction:** Known as lymphedema, this occurs when lymphatics fail to drain the small amount of interstitial fluid that normally leaks out (e.g., Filariasis or post-mastectomy) [3]. **High-Yield NEET-PG Pearls:** * **Starling’s Law:** Edema occurs when the balance between hydrostatic and oncotic pressure is disrupted [1]. * **Transudate vs. Exudate:** Transudate has a low specific gravity (<1.012) and low protein content (<3g/dL). Exudate has a high specific gravity (>1.020) and high protein content (>3g/dL). * **Sodium Retention:** Secondary salt and water retention (e.g., in Renal Failure) is another major cause of non-inflammatory edema. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 186-187. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 124. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 124-126.

Question 573: Toll-like receptors recognize bacterial products and stimulate immune response by which mechanism?

A. Perforin and granzyme-mediated apoptosis
B. FADD ligand apoptosis
C. Transcription of nuclear factors, including NF-κB, which recruits cytokines (Correct Answer)
D. Cyclin activation

Explanation: **Explanation:** **Toll-like receptors (TLRs)** are a class of Pattern Recognition Receptors (PRRs) located on cell membranes and endosomes. They recognize **Pathogen-Associated Molecular Patterns (PAMPs)**, such as bacterial lipopolysaccharide (LPS) or double-stranded RNA [1]. 1. **Why Option C is correct:** When a TLR binds to its specific ligand, it triggers a complex intracellular signaling cascade (often involving the adapter protein **MyD88**). This leads to the activation of transcription factors, most notably **Nuclear Factor-kappa B (NF-̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀̀**Nuclear Factor-kappa B (NF-́B)** and **Interferon Regulatory Factors (IRFs)** [1]. NF-kB translocates to the nucleus to stimulate the transcription of genes encoding pro-inflammatory cytokines (e.g., TNF, IL-1, IL-6) and chemokines, which initiate the acute inflammatory response and recruit leukocytes. 2. **Why other options are incorrect:** * **Options A & B:** Perforin/granzyme and FADD (Fas-Associated Death Domain) are mechanisms associated with **Apoptosis** (programmed cell death), specifically the extrinsic and cytotoxic T-cell pathways. TLRs primarily function to activate the immune response and inflammation, not to directly execute apoptosis. * **Option D:** Cyclin activation regulates the **cell cycle** and mitosis. While immune activation can eventually lead to lymphocyte proliferation, it is not the primary signaling mechanism of TLRs. **High-Yield Clinical Pearls for NEET-PG:** * **TLR-4** recognizes **LPS** (Gram-negative bacteria). * **TLR-2** recognizes **Peptidoglycans** (Gram-positive bacteria). * **TLR-3, 7, 8, and 9** are endosomal and recognize viral/bacterial nucleic acids. * **NF-́B** is considered the "central mediator" of the inflammatory response. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 142.

Question 574: The LE cell in Romanowsky-stained preparation is:

A. Monocyte
B. Neutrophil (Correct Answer)
C. Eosinophil
D. Lymphocyte

Explanation: **Explanation:** The **LE (Lupus Erythematosus) cell** is a classic laboratory finding historically used in the diagnosis of Systemic Lupus Erythematosus (SLE). It is defined as a **mature neutrophil** (polymorphonuclear leukocyte) that has ingested a spherical, denatured nuclear mass of another cell [1]. **Underlying Mechanism:** The process involves **Antinuclear Antibodies (ANA)**, specifically anti-histone antibodies. When a cell nucleus is damaged, these antibodies bind to the exposed chromatin, converting it into a homogenous, amorphous material called an **"LE body"** or hematoxylin body [1]. This opsonized material is then phagocytosed by a healthy, viable phagocyte—most commonly a **neutrophil**. Under Romanowsky stains (like Wright’s or Giemsa), the LE cell appears as a neutrophil with its own nucleus pushed to the periphery by a large, pale-purple, structureless inclusion body [1]. **Analysis of Options:** * **B. Neutrophil (Correct):** The neutrophil is the primary phagocytic cell involved in the formation of the LE cell phenomenon in vitro [1]. * **A, C, & D (Incorrect):** While monocytes (Option A) can occasionally ingest LE bodies (forming a "Tart cell"), the classic definition and the most frequent cell type seen in a positive LE prep is the neutrophil [1]. Eosinophils and lymphocytes are not typically involved in this specific phagocytic process. **High-Yield Clinical Pearls for NEET-PG:** * **Hargraves’ Cell:** Another name for the LE cell (discovered by Malcolm Hargraves). * **In Vitro Phenomenon:** The LE cell is an *in vitro* finding (requires trauma to cells during blood processing) and is rarely seen in vivo (except in pleural or joint effusions) [1]. * **Sensitivity vs. Specificity:** It is positive in 50–70% of SLE patients but is **not specific**, as it can be seen in other autoimmune diseases (e.g., Scleroderma, RA). * **Current Status:** It has largely been replaced by more sensitive and specific tests like **ANA (Immunofluorescence)** and **Anti-dsDNA** [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 230. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 226-227.

Question 575: Tuberous sclerosis is inherited as?

A. Autosomal dominant (Correct Answer)
B. Autosomal recessive
C. X-linked dominant
D. X-linked recessive

Explanation: **Explanation:** Tuberous Sclerosis Complex (TSC) is a multi-system neurocutaneous syndrome inherited in an **Autosomal Dominant** pattern [1], [2]. It is primarily caused by mutations in the tumor suppressor genes **TSC1 (Hamartin)** on chromosome 9q34 or **TSC2 (Tuberin)** on chromosome 16p13. These proteins normally inhibit the **mTOR pathway**; their loss leads to unregulated cell growth and the formation of hamartomas across various organs [1]. * **Why Autosomal Dominant is correct:** TSC follows the "Two-Hit Hypothesis." While the inheritance is dominant (only one defective allele is inherited), a somatic mutation in the second allele is required for tumor formation [3]. It shows high penetrance but **variable expressivity**, meaning clinical severity varies widely even within the same family. * **Why other options are incorrect:** * **Autosomal Recessive:** These disorders usually involve enzyme deficiencies (e.g., Lysosomal storage diseases). TSC involves structural/regulatory proteins [4]. * **X-linked:** TSC affects males and females equally and shows male-to-male transmission, which rules out X-linked inheritance. **High-Yield Clinical Pearls for NEET-PG:** * **Vogt’s Triad:** Adenoma sebaceum (facial angiofibromas), Mental retardation, and Seizures (present in only ~30% of cases) [1]. * **Dermatological markers:** Ash-leaf spots (earliest sign, seen under Wood’s lamp), Shagreen patches (connective tissue nevi), and Periungual fibromas (Koenen tumors) [1]. * **Organ involvement:** * **Brain:** Subependymal Giant Cell Astrocytoma (SEGA), Cortical tubers [1]. * **Kidney:** Angiomyolipoma (often bilateral) [1]. * **Heart:** Rhabdomyoma (often regresses spontaneously) [1]. * **Lung:** Lymphangioleiomyomatosis (LAM) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1318-1319. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 724-725. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58.

Question 576: Which type of hypersensitivity reaction is mediated by immune complexes?

A. Type IV
B. Type I
C. Type II
D. Type III (Correct Answer)

Explanation: **Explanation:** **Type III Hypersensitivity** is the correct answer because it is specifically defined as **Immune Complex-Mediated**. In this reaction, antigen-antibody (IgG or IgM) complexes form in the circulation and are subsequently deposited in tissues (like blood vessel walls, synovial membrane, or glomerular basement membrane) [1]. These deposits activate the complement system (classical pathway), leading to the recruitment of neutrophils, release of lysosomal enzymes, and subsequent tissue damage (vasculitis) [2]. **Analysis of Incorrect Options:** * **Type I (Immediate):** Mediated by **IgE antibodies** binding to mast cells and basophils. It involves the release of histamine and is seen in anaphylaxis and asthma. * **Type II (Cytotoxic):** Mediated by **IgG or IgM** antibodies directed against antigens present on **specific cell surfaces** or extracellular matrix (e.g., Rheumatic fever, Myasthenia gravis). * **Type IV (Delayed):** This is **cell-mediated**, involving T-lymphocytes (CD4+ or CD8+) rather than antibodies. Examples include the Mantoux test and contact dermatitis. **High-Yield NEET-PG Pearls:** * **Coombs and Gell Classification:** The standard system used to classify these four types. * **Classic Examples of Type III:** Systemic Lupus Erythematosus (SLE), Post-Streptococcal Glomerulonephritis (PSGN), Rheumatoid Arthritis, and **Arthus Reaction** (localized) or **Serum Sickness** (systemic) [2][3]. * **Key Feature:** Look for "low complement levels" (C3, C4) in clinical stems, as complement is consumed during the formation of these complexes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 214-216. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 172-173. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 215-216.

Question 577: What is the starting point of apoptosis for programmed cell death?

A. Activation of endonuclease
B. Release of enzymes
C. Accumulation of calcium
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **None of the above** because the "starting point" or the fundamental biochemical hallmark of apoptosis is the **activation of Caspases** [1]. #### Why the correct answer is right: Apoptosis is a highly regulated, energy-dependent process of programmed cell death. It is divided into two phases: the **Initiation phase** and the **Execution phase** [1]. Regardless of the pathway (Intrinsic/Mitochondrial or Extrinsic/Death Receptor), the process is initiated by the activation of **initiator caspases** (Caspase 8, 9, or 10) [2]. These then activate **executioner caspases** (Caspase 3, 6, and 7), which carry out the final stages of cell destruction. None of the listed options represent the actual starting trigger. #### Why the other options are incorrect: * **A. Activation of endonuclease:** This occurs during the **execution phase** [1]. Endonucleases (like CAD - Caspase Activated DNase) cleave DNA into fragments of 180–200 base pairs, leading to the characteristic "DNA laddering" seen on electrophoresis. It is a downstream event, not the starting point. * **B. Release of enzymes:** This is more characteristic of **Necrosis**, where lysosomal enzymes leak out and cause enzymatic digestion of the cell and surrounding tissue. In apoptosis, enzymes (caspases) are activated in a controlled manner, and cellular contents do not leak out. * **C. Accumulation of calcium:** While increased cytosolic calcium can trigger various cell injury pathways and activate certain enzymes, it is a hallmark of **irreversible cell injury** and necrosis (leading to mitochondrial membrane damage) rather than the specific starting point of the apoptotic cascade. #### NEET-PG High-Yield Pearls: * **Caspases:** These are Cysteine proteases that cleave after Aspartic acid residues. * **Intrinsic Pathway:** Triggered by the release of **Cytochrome c** from the mitochondria into the cytosol, which binds to **Apaf-1** to form the **Apoptosome** [1]. * **Extrinsic Pathway:** This pathway is initiated by engagement of plasma membrane death receptors like Fas (CD95) [2]. * **Morphological Hallmark:** The most characteristic feature of apoptosis is **Chromatin Condensation** (Pyknosis). * **Phagocytosis:** Apoptotic cells express **Phosphatidylserine** on their outer membrane leaflet ("eat-me" signal) for recognition by macrophages without inducing inflammation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67.

Question 578: Gingival biopsy is used for the diagnosis of which of the following conditions?

A. Scurvy
B. Sarcoidosis
C. Amyloidosis (Correct Answer)
D. Systemic Lupus Erythematosus (SLE)

Explanation: ### Explanation **Correct Option: C. Amyloidosis** Amyloidosis is a condition characterized by the extracellular deposition of misfolded fibrillar proteins (amyloid) in various tissues [1]. While a **rectal biopsy** or **abdominal fat pad aspiration** are the traditional screening methods of choice due to their high sensitivity (approx. 70-80%) and low invasiveness, a **gingival biopsy** is a well-established diagnostic alternative. The gingiva is highly vascular, and amyloid deposits are frequently found within the walls of gingival blood vessels or the connective tissue stroma [2]. When stained with **Congo Red**, these deposits exhibit characteristic **apple-green birefringence** under polarized light [2]. **Analysis of Incorrect Options:** * **A. Scurvy:** Diagnosis is primarily clinical (gingival bleeding, petechiae, corkscrew hairs) and confirmed by serum ascorbic acid levels, not biopsy. * **B. Sarcoidosis:** While sarcoidosis can affect any organ, the gold standard for diagnosis is a biopsy of the **lung (transbronchial)** or **lymph nodes**, showing non-caseating granulomas. * **D. SLE:** Diagnosis is based on clinical criteria (ACR/SLICC) and serology (ANA, Anti-dsDNA). If a biopsy is performed, it is typically a **skin biopsy** (Lupus Band Test) or a **renal biopsy** to grade lupus nephritis. **NEET-PG High-Yield Pearls:** * **Most common site for biopsy in Systemic Amyloidosis:** Abdominal fat pad (easiest) or Rectum (most reliable). * **Stain of choice:** Congo Red [2]. * **Microscopy:** Polarized light shows apple-green birefringence [2]. * **Electron Microscopy:** Shows non-branching fibrils (7.5–10 nm diameter) [2]. * **Precursor proteins:** AL (Light chain - Plasma cell dyscrasias), AA (Serum Amyloid Associated - Chronic inflammation), and Transthyretin (TTR - Senile/Familial) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269.

Question 579: Which of the following is NOT true regarding Langerhans Cell Histiocytosis (LCH)?

A. Papular trunk lesions with scaling and crusting
B. Ulcerative nodules on mucosa
C. Calvarial defect with map lesions and floating teeth
D. CD-68 positive (Correct Answer)

Explanation: **Langerhans Cell Histiocytosis (LCH)** is a clonal proliferation of dendritic cells (Langerhans cells) that share characteristics with antigen-presenting cells of the skin [2]. ### **Explanation of the Correct Answer** **Option D is NOT true** because the definitive immunohistochemical (IHC) markers for LCH are **CD1a, S-100, and Langerin (CD207)**. While CD68 is a marker for the monocyte/macrophage lineage, LCH cells are derived from dendritic cells. Although some LCH cases may show weak focal positivity for CD68, it is neither specific nor a primary diagnostic marker [1]. The presence of **Birbeck granules** (tennis-racket shaped organelles) on electron microscopy is the pathognomonic gold standard [1]. ### **Analysis of Incorrect Options** * **Option A:** Cutaneous involvement is common, especially in the Letterer-Siwe subtype (multifocal multisystem LCH). It typically presents as a **seborrheic dermatitis-like rash** with papules, scaling, and crusting on the trunk and scalp. * **Option B:** Mucosal involvement can occur, presenting as painful **ulcerative nodules** or gingival swelling, particularly in multisystem disease. * **Option C:** Bone is the most common site of involvement (Eosinophilic Granuloma). **"Map-like" or "punched-out" lytic lesions** in the calvarium are classic. In the mandible, alveolar bone loss leads to the characteristic **"floating-in-air" teeth** appearance on X-ray. ### **High-Yield Clinical Pearls for NEET-PG** * **BRAF V600E Mutation:** Present in about 50% of LCH cases (important for targeted therapy) [2]. * **Hand-Schüller-Christian Triad:** Calvarial bone defects, Diabetes Insipidus, and Exophthalmos. * **Letterer-Siwe Disease:** Seen in infants (<2 years); involves skin, liver, spleen, and bone marrow; poor prognosis. * **Eosinophilic Granuloma:** Unifocal, usually in the skeletal system of older children or adults; benign course. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 630. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630.

Question 580: Which of the following is not a feature of red infarction?

A. Venous occlusion
B. Occurs in organs having dual circulation
C. Occurs in solid organs (Correct Answer)
D. Occurs in previously congested tissues

Explanation: ### Explanation In pathology, infarcts are classified based on their color, which reflects the amount of hemorrhage [1]. **Red (hemorrhagic) infarcts** occur when blood can collect in the necrotic area, whereas **white (pale) infarcts** occur in solid organs with end-arterial circulation [1]. **Why Option C is the Correct Answer:** Red infarcts typically occur in **loose tissues** (like the lungs) or organs with dual blood supply [1]. In contrast, **solid organs** (such as the heart, spleen, and kidneys) have high tissue density and "end-arterial" circulation [1]. When an artery is blocked in these organs, the solid nature of the tissue limits the amount of hemorrhage that can seep into the necrotic area from adjacent capillary beds, resulting in a **white (pale) infarct** [1]. **Analysis of Incorrect Options:** * **Option A (Venous occlusion):** This is a classic cause of red infarcts [1]. When venous outflow is blocked (e.g., testicular torsion), blood backs up and causes massive hemorrhage into the tissue. * **Option B (Dual circulation):** Organs like the lungs (pulmonary and bronchial arteries) or liver (portal vein and hepatic artery) develop red infarcts because the secondary blood supply continues to pump blood into the necrotic zone. * **Option C (Previously congested tissues):** If a tissue is already sluggish with blood (chronic passive congestion), an infarct will naturally be hemorrhagic (red) [1]. **NEET-PG High-Yield Pearls:** * **White Infarcts:** Occur in solid organs with single/end-arterial supply (Heart, Spleen, Kidney) [1]. * **Red Infarcts:** Occur in loose tissues (Lungs), dual circulation (Lungs, Small Intestine), venous occlusion (Torsion), or upon **reperfusion** (e.g., after angioplasty) [1]. * **Morphology:** Most infarcts are **wedge-shaped**, with the apex pointing toward the occluded vessel [1]. * **Microscopy:** The hallmark of most infarcts is **coagulative necrosis** (except the brain, which undergoes liquefactive necrosis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 140.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free